Literature DB >> 10723095

Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha.

E Tufvesson1, G Westergren-Thorsson.   

Abstract

Important constituents of extracellular matrix are collagen, fibronectin, hyaluronan, and various types of proteoglycans, such as versican, perlecan, decorin, and biglycan. Remodeling of extracellular matrix occurs continuously and is affected by various cytokines. The aim of this study was to investigate how interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha), separately and in combination, alter fibroblast proliferation, as well as the production of extracellular matrix molecules produced by human fibroblasts from lung. Fibroblast proliferation was inhibited significantly by all treatments, by 12% with IL-1beta and by 16% with TNF-alpha. The combination of IL-1beta and TNF-alpha increased the inhibition further, by 27%. Hyaluronan production was increased by all treatments: 1.7-fold by IL-1beta and 1.5-fold by TNF-alpha. The combination of the two gave a further increase (2.5-fold). Similarly, the production of total proteoglycans was increased. The small proteoglycans, decorin, and biglycan, were regulated differently. Decorin production was inhibited by about 34% by all treatments, while biglycan was upregulated 1.3-fold by TNF-alpha. Versican was upregulated by IL-1beta (1.7-fold), whereas TNF-alpha was without effect. Perlecan was mostly unaffected. The changes in protein production of the various proteoglycans were due to increased transcription, as mRNA levels were also changed to the same extent. Synthesis of mRNA for collagen type I was inhibited by up to 75% with the IL-1beta/TNF-alpha combination. The separate cytokines also decreased the level of collagen type I mRNA, but to a lesser extent: 60% with IL-1beta and 40% with TNF-alpha. In summary, our study indicates that these proinflammatory cytokines affect the regulation of extracellular matrix production, which is of importance for the inflammatory process. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10723095     DOI: 10.1002/(sici)1097-4644(20000501)77:2<298::aid-jcb12>3.0.co;2-d

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  26 in total

1.  Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.

Authors:  M Kolb; P J Margetts; D C Anthony; F Pitossi; J Gauldie
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Effects of raised-intensity phonation on inflammatory mediator gene expression in normal rabbit vocal fold.

Authors:  Erik R Swanson; Tsunehisa Ohno; Dave Abdollahian; C Gaelyn Garrett; Bernard Rousseau
Journal:  Otolaryngol Head Neck Surg       Date:  2010-10       Impact factor: 3.497

3.  Reduction of adhesion formation and promotion of wound healing after laminectomy by pharmacological inhibition of pro-inflammatory cytokines: an experimental study in the rat.

Authors:  Kjell Olmarker
Journal:  Eur Spine J       Date:  2010-07-10       Impact factor: 3.134

Review 4.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Role of hyaluronan and hyaluronan-binding proteins in human asthma.

Authors:  Jiurong Liang; Dianhua Jiang; Yoosun Jung; Ting Xie; Jennifer Ingram; Tony Church; Simone Degan; Maura Leonard; Monica Kraft; Paul W Noble
Journal:  J Allergy Clin Immunol       Date:  2011-05-13       Impact factor: 10.793

6.  Revealing cytokine-induced changes in the extracellular matrix with secondary ion mass spectrometry.

Authors:  Adam J Taylor; Buddy D Ratner; Lee D K Buttery; Morgan R Alexander
Journal:  Acta Biomater       Date:  2014-12-15       Impact factor: 8.947

7.  Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy.

Authors:  K Fujii; M B Karpova; K Asagoe; O Georgiev; R Dummer; M Urosevic-Maiwald
Journal:  Leukemia       Date:  2015-04-27       Impact factor: 11.528

8.  Altered fibroblast proteoglycan production in COPD.

Authors:  Oskar Hallgren; Kristian Nihlberg; Magnus Dahlbäck; Leif Bjermer; Leif T Eriksson; Jonas S Erjefält; Claes-Göran Löfdahl; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2010-05-11

Review 9.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

10.  Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Daniel Lajeunesse; Hassan Fahmi; Nicolas Duval; Johanne Martel-Pelletier
Journal:  Bone       Date:  2008-04-26       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.